Literature DB >> 21937153

Recent progress in synthesis and bioactivity studies of indolizines.

Girija S Singh1, Edward E Mmatli.   

Abstract

The present review describes the recent progress in synthetic approaches to construct indolizine framework (including partially or wholly reduced ring) and the design of such compounds with potential biological activity. The methods of synthesis are classified as the Tschitschibabin reaction, 1,3-dipolar cycloadditions, cyclisation reactions depending on the position of bond formation, and other methods. The biological activities include antimicrobial activity, antioxidant activity, anti-inflammatory activity, anticonvulsant activity, enzymes inhibition activity and activity as calcium entry blocker. Consequently this review emphasizes the significant development in synthetic methods of indolizines during the current decade, and the importance of indolizines in drug discovery.
Copyright © 2011 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21937153     DOI: 10.1016/j.ejmech.2011.08.042

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  22 in total

1.  One-pot synthesis of highly substituted N-fused heteroaromatic bicycles from azole aldehydes.

Authors:  Victor K Outlaw; Felipe B d'Andrea; Craig A Townsend
Journal:  Org Lett       Date:  2015-03-27       Impact factor: 6.005

2.  Iodine-mediated sp³ C-H functionalization of methyl ketones: a one-pot synthesis of functionalized indolizines via the 1,3-dipolar cycloaddition reaction between pyridinium ylides and ynones.

Authors:  Issa Yavari; Jamil Sheykhahmadi; Maryam Naeimabadi; Mohammad Reza Halvagar
Journal:  Mol Divers       Date:  2017-01-11       Impact factor: 2.943

Review 3.  Alkynoates as Versatile and Powerful Chemical Tools for the Rapid Assembly of Diverse Heterocycles under Transition-Metal Catalysis: Recent Developments and Challenges.

Authors:  Imtiaz Khan; Aliya Ibrar; Sumera Zaib
Journal:  Top Curr Chem (Cham)       Date:  2021-01-05

4.  Unusual Friedlander reactions: a route to novel quinoxaline-based heterocycles.

Authors:  Tharallah A Shoker; Khaled I Ghattass; James C Fettinger; Mark J Kurth; Makhluf J Haddadin
Journal:  Org Lett       Date:  2012-07-11       Impact factor: 6.005

5.  Design, synthesis and biological evaluation of indolizine derivatives as HIV-1 VIF-ElonginC interaction inhibitors.

Authors:  Wenlin Huang; Tao Zuo; Hongwei Jin; Zhenming Liu; Zhenjun Yang; Xianghui Yu; Liangren Zhang; Lihe Zhang
Journal:  Mol Divers       Date:  2013-02-03       Impact factor: 2.943

6.  Synthesis of 6a,6b,13,13a-tetrahydro-6H-5-oxa-12a-azadibenzo[a,g]fluorene derivatives via cycloaddition reactions of isoquinolinium salts with 3-nitrochromenes.

Authors:  Jun Fang; Chao-Guo Yan
Journal:  Mol Divers       Date:  2013-10-22       Impact factor: 2.943

7.  Palladium catalyzed synthesis of indolizines via the carbonylative coupling of bromopyridines, imines and alkynes.

Authors:  Sébastien A Roy; José Zgheib; Cuihan Zhou; Bruce A Arndtsen
Journal:  Chem Sci       Date:  2020-12-22       Impact factor: 9.825

8.  Anti-tubercular activity and molecular docking studies of indolizine derivatives targeting mycobacterial InhA enzyme.

Authors:  Katharigatta N Venugopala; Sandeep Chandrashekharappa; Pran Kishore Deb; Christophe Tratrat; Melendhran Pillay; Deepak Chopra; Nizar A Al-Shar'i; Wafa Hourani; Lina A Dahabiyeh; Pobitra Borah; Rahul D Nagdeve; Susanta K Nayak; Basavaraj Padmashali; Mohamed A Morsy; Bandar E Aldhubiab; Mahesh Attimarad; Anroop B Nair; Nagaraja Sreeharsha; Michelyne Haroun; Sheena Shashikanth; Viresh Mohanlall; Raghuprasad Mailavaram
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051

9.  [1-Meth-oxy-3-(pyridin-2-yl)indolizin-2-yl](pyridin-2-yl)methanone.

Authors:  Tobias Kloubert; Robert Kretschmer; Helmar Görls; Matthias Westerhausen
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-08-04

10.  5''-(4-Meth-oxy-benzyl-idene)-1'-(4-meth-oxy-phen-yl)-1''-methyl-1',2',3',5',6',7',8',8a'-octa-hydro-dispiro-[acenaphthyl-ene-1,3'-indolizine-2',3''-piperidine]-2,4''(1H)-dione.

Authors:  J Suresh; R A Nagalakshmi; S Sivakumar; R Ranjith Kumar; P L Nilantha Lakshman
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-01-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.